It’s crucial that patients use pharmaceutical products appropriately if they are to experience the intended effects. Unfortunately, non-adherence to prescriptions and misuse of medicines are global challenges. Studies have shown clear adherence benefits when patients receive their medications prepackaged in doses tailored for them. Mylan supports appropriate use. Mylan works with its customers in Europe that offer individual dose dispensing services to their patients.
Mylan provides online portals and digital solutions, such as the MyFreshStart™ program, which educates patients about a variety of medical conditions and ways to better manage them. Mylan’s support of the WiZVi™ application in France allows greater connectivity between patients and their doctors and pharmacists. Our sponsorship of Seguilaterapia programs in Italy promotes therapeutic adherence by reminding patients to take their medication or refill prescriptions. Mylan also adapts its packaging with symbols and pictograms that illustrate dosage schedules.
To support patients diagnosed with HCV in India, we developed a mobile app called HepBUZZ™. It helps HCPs choose appropriate medications; simplify therapy options based on genotype, liver status and patient profile; and provide real-time guidance for prescribers to check drug interactions
and understand a patient’s overall condition.